Benzinga | Aug 5, 2021 08:06AM EDT

WAVE Life Sciences Q2 EPS $(0.78) Misses $(0.64) Estimate, Sales $2.78M Down From $3.03M YoY

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.64) by 21.88 percent. This is a 32.17 percent increase over losses of $(1.15) per share from the same period last year. The company reported $2.78 million in sales this quarter. This is a 8.29 percent decrease over sales of $3.03 million the same period last year.